Why the study?
Does atrial natriuretic peptide (ANP) improve proximal coronary dimension and coronary blood flow in humans?
Population
17 patients
Design
Case_series
Follow-up
more than 30 minutes
Authors
Loading...
ANP coronary dilation remains investigational; case report leaves open any therapeutic role in ischemia pending controlled trials.
Does atrial natriuretic peptide (ANP) improve proximal coronary dimension and coronary blood flow in humans?
Bolus injection of ANP causes marked, sustained proximal coronary dilation with minor systemic hemodynamic changes, suggesting potential utility in treating ischemia.
Chu et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: